Surgical And Clinical Outcomes With Neoadjuvant Atezolizumab In Resectable Stage Ib-Iiib Nsclc: Lcmc3 Trial Primary Analysis
JOURNAL OF THORACIC ONCOLOGY(2021)
Key words
Neoadjuvant, atezolizumab, Early Stage Lung Cancer
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined